Diametric Capital’s Zimmer Biomet ZBH Stock Holding History

Diametric Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,604	Closed	-$381K	–	385
2024 Q4	$381K	Buy	+3,604	New	+$387K	0.26%	112
2024 Q2	–	Sell	-8,383	Closed	-$1.11M	–	480
2024 Q1	$1.11M	Buy	+8,383	New	+$1.05M	0.61%	41
2023 Q4	–	Sell	-16,081	Closed	-$1.8M	–	400
2023 Q3	$1.8M	Buy	16,081 +12,545	+355%	+$1.59M	0.75%	30
2023 Q2	$515K	Buy	+3,536	New	+$481K	0.23%	123
2023 Q1	–	Sell	-12,130	Closed	-$1.55M	–	425
2022 Q4	$1.55M	Buy	+12,130	New	+$1.41M	0.74%	23
2022 Q2	–	Sell	-10,000	Closed	-$1.28M	–	352
2022 Q1	$1.28M	Buy	+10,000	New	+$1.21M	0.71%	36
2019 Q4	–	Sell	-9,866	Closed	-$1.31M	–	153
2019 Q3	$1.31M	Buy	+9,866	New	+$1.27M	1.08%	33

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Diametric Capital's ZBH Position: Q1 2025 in Review

Diametric Capital sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 3,604 shares — an estimated $381K sold.

Diametric Capital first reported a position in ZBH in Q3 2019 and held it in 7 quarters. The position peaked at $1.8M in Q3 2023. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

Diametric Capital reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
Diametric Capital sold 3,604 Zimmer Biomet shares in Q1 2025, an estimated $381K.
Diametric Capital first reported a position in Zimmer Biomet in Q3 2019 and held it in 7 quarters.
Diametric Capital's Zimmer Biomet position peaked at $1.8M in Q3 2023.
1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Diametric Capital's 13F filing for Q1 2025, filed 14 May 2025.